As of 2026-09-18, the Intrinsic Value of Revolution Medicines Inc (RVMD) is -21.59 USD. This RVMD valuation is based on the model Peter Lynch Fair Value. With the current market price of 196.94 USD, the upside of Revolution Medicines Inc is -110.96%.
Based on its market price of 196.94 USD and our intrinsic valuation, Revolution Medicines Inc (RVMD) is overvalued by 110.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -21.59 - -21.59 | -21.59 | -110.96% |
| P/E | (101.46) - (128.23) | (115.60) | -158.7% |
| DDM - Stable | (46.41) - (208.08) | (127.25) | -164.6% |
| DDM - Multi | (10.45) - (36.53) | (16.26) | -108.3% |
| Market Cap (mil) | 41,869.44 |
| Beta | 2.78 |
| Outstanding shares (mil) | 212.60 |
| Enterprise Value (mil) | 42,089.98 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.19% |
| Cost of Debt | 5.00% |
| WACC | 8.17% |